Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas

William N. William; Anne S. Tsao; Lei Feng; Lawrence E. Ginsberg; J. Jack Lee; Merrill S. Kies; Bonnie S. Glisson; Edward S. Kim

首页> 外文期刊>The oncologist >Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas

【24h】

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas

机译：顺铂，多西他赛和厄洛替尼在复发和/或转移性头颈部鳞状细胞癌患者中的单臂II期研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Lessons Learned.

机译：得到教训。

著录项

来源
《The oncologist》 |2018年第5期|共页
作者
William N. William; Anne S. Tsao; Lei Feng; Lawrence E. Ginsberg; J. Jack Lee; Merrill S. Kies; Bonnie S. Glisson; Edward S. Kim;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas [J] . William William N. Jr., Tsao Anne S., Feng Lei, The oncologist . 2018,第5期

机译：患有复发性和/或转移头和颈部鳞状细胞癌患者的单臂，Coisplatin，Docetaxel和Erlotinib的单臂研究
2. Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study. [J] . Siu LL, Soulieres D, Chen EX, Journal of Clinical Oncology . 2007,第16期

机译：厄洛替尼和顺铂在复发或转移性头颈部鳞状细胞癌患者中进行的I / II期临床试验：玛格丽特公主医院II期联合体和加拿大国家癌症研究所临床试验小组研究。
3. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. [J] . Schoffski P, Catimel G, Planting AS, Annals of oncology: official journal of the European Society for Medical Oncology . 1999,第1期

机译：多西紫杉醇和顺铂：在局部晚期，复发或转移性头颈部鳞状细胞癌患者中的有效方案。 EORTC早期临床研究小组II期研究的结果。
4. Interstitial photodynamic therapy in combination with Cetuximab for recurrent head and neck squamous cell carcinoma [C] . Nestor Rigual, Ambujakshan Dildeep, Gal Shafirstein Conference on photonic therapeutics and diagnostics IX . 2013

机译：间质性光动力疗法联合西妥昔单抗治疗复发性头颈部鳞状细胞癌
5. Inflammatory mechanisms of chemokine receptor 7 expression in metastatic squamous cell carcinoma of the head and neck (SCCHN). [D] . Mburu, Yvonne K. 2011

机译：趋化因子受体7在头颈部转移性鳞状细胞癌（SCCHN）中表达的炎症机制。
6. Single Arm Phase II Study of Cisplatin Docetaxel and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas [O] . William N. William Jr., *, Anne S. Tsao, 2018

机译：顺铂多西他赛和厄洛替尼在复发性和/或转移性头颈部鳞状细胞癌患者中的单臂II期研究
7. Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study [O] . J. Guigay, J. Fayette, A.F. Dillies, 2015

机译：西妥昔单抗，Docetaxel和顺铂作为复发或转移性头颈鳞状细胞癌患者的一线治疗：多中心，II期Gortec学习

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas

摘要

著录项

相似文献

相关主题

期刊订阅